tm
Seeing Is Believing
tm
Seeing Is Believing
Healthcare - Sector
Regulus Therapeutics's activity chart (see below) currently has 59 price targets and 76 ratings on display.
Analysts average stock forecasts to be materialized ratio is 36.55% with an average time for these price targets to be met of 134.5 days.
Most recent stock forecast was given by from WELLS FARGO on 01-May-2025. First documented stock forecast 28-Feb-2014.
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 01-May-2025
$9
$0.84 (10.29%)
$6
1 years 5 months 20 days ago
(01-May-2025)
1/2 (50%)
$1.15 (14.65%)
34
Buy Since 31-May-2024
$7
$-1.16 (-14.22%)
$8
1 years 5 months 21 days ago
(30-Apr-2025)
3/4 (75%)
$-0.98 (-12.28%)
302
Buy Since 19-Mar-2024
$11
$2.84 (34.80%)
1 years 5 months 21 days ago
(30-Apr-2025)
0/2 (0%)
$3.02 (37.84%)
Buy Since 05-Jan-2018
$6
1 years 6 months 20 days ago
(31-Mar-2025)
1/2 (50%)
$3.64 (154.24%)
408
Buy Since 18-Mar-2024
$10
$1.84 (22.55%)
1 years 7 months 7 days ago
(14-Mar-2025)
0/6 (0%)
$8.52 (575.68%)
What is RGLS (Regulus Therapeutics) average time for price targets to be met?
Which analyst most recently updated their price target on RGLS (Regulus Therapeutics)?
Which analyst has the most public recommendations on RGLS (Regulus Therapeutics)?
Which analyst is the currently most bullish on RGLS (Regulus Therapeutics)?
Which analyst is the currently most reserved on RGLS (Regulus Therapeutics)?
